| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.033 | 0.8 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.036 | 0.8 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.8 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |